Upload Avatar (500 x 500)
Huan Liu
huanliu@xmu.edu.cn
Chinese, English
Fujian
Xiamen University
Medical
  • 2001-2005 Bachelor's: Nanjing Agricultural University, Biotechnology
  • 2005-2008 Master's: Nanjing Agricultural University, Microbiology
  • 2008-2011 Ph.D.: Kunming Institute of Zoology, Chinese Academy of Sciences
  • 2011-2012 - Kunming Institute of Zoology, Chinese Academy of Sciences - Assistant Researcher
  • 2012-2017 - MD Anderson Cancer Center, USA - Postdoctoral Fellow
  • 2017-2020 - MD Anderson Cancer Center, USA - Lecturer
  • 2020 - Cornell University Houston Methodist Hospital Cancer Center, USA - Research Scientist
  • 2021-present - Xiamen University School of Medicine - Professor
  • National High-Level Young Talent (2022)
  • Fujian Outstanding Youth Fund Recipient (2022)
  • Minjiang Scholar Distinguished Professor (2021)
Pathogenesis and targeted therapy of multiple myeloma
Feedback remodeling of bone marrow microenvironment on myeloma cells
  • m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease, Rui Liu, Yuping Zhong, Rui Chen, Chengchao Chu, Gang Liu, Yong Zhou, Yazhu Huang, Zhihong Fang and Huan Liu, 2022
  • Osteocyte CIITA aggravates osteolytic bone lesions in myeloma, Huan Liu, Jin He, Rozita Bagheri-Yarmand, Zongwei Li, Rui Liu, Zhiming Wang, Duc-hiep Bach, Yung-hsing Huang, Pei Lin, Theresa Guise, Robert F. Gagel, and Jing Yang, 2022
  • Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance, Zhiming Wang, Jin He, Duc-Hiep Bach, Yung-Hsing Huang, Zongwei Li, Huan Liu, Pei Lin, Jing Yang, 2022
  • Bacterial infections exacerbate myeloma bone disease, Rui Liu, Yuping Zhong, Rui Chen, Shiyi Chen, Yazhu Huang, Huan Liu, 2022
  • Promotion of bone lesions through the myeloma integrin α6-mediated osteolytic signaling, Huan Liu, Zhiming Wang, Jin He, Zongwei Li, Jerry Y. Gao, Rui Liu, Pei Lin, and Jing Yang, 2021
  • Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma, Zongwei Li, Huan Liu, Jin He, Zhiqiang Wang, Zheng Yin, Gichun You, Zhiming Wang, Richard E Davis, Pei Lin, P Leif Bergsagel, Elisabet E Manasanch, Stephen T C Wong, Nestor F Esnaola, Jenny C Chang, Robert Z Orlowski, Qing Yi, Jing Yang, 2021
  • TAS-102 has a tumoricidal activity in multiple myeloma, Guoli Li, Huan Liu, Jin He, Zongwei Li, Zhiming Wang, Shan Zhou, Guopei Zheng, Zhimin He, Jing Yang, 2020
  • Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells, Zhiqiang Liu, Huan Liu, Jin He, Jingda Xu, Sheeba K. Thomas, Elisabet E Manasanch, Donna Weber, Qiang Tong, Jing Yang, 2020
  • Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease, Huan Liu, Jin He, Su Pin Koh, Yuping Zhong, Zhiqiang Liu, Zhiqiang Wang, Yujin Zhang, Zongwei Li, Bjorn T. Tam, Pei Lin, Min Xiao, Ken H. Young, Behrang Amini, Michael W. Starbuck, Hans C. Lee, Nora M. Navone, Richard E. Davis, Qiang Tong, P. Leif Bergsagel, Jian Hou, Qing Yi, Robert Z. Orlowski, Robert F. Gagel, Jing Yang, 2019
  • Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma, Huan Liu, Zhiqiang Liu, Juan Du, Jin He, Pei Lin, Behrang Amini, Michael W. Starbuck, Nora Novane, Jatin J. Shah, Richard E. Davis, Jian Hou, Robert F. Gagel, Jing Yang, 2016
  • C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis, Jing Yang, Zhiqiang Liu, Huan Liu, Jin He, Jianling Yang, Pei Lin, Qiang Wang, Juan Du, Wencai Ma, Zheng Yin, Eric Davis, Robert Z. Orlowski, Jian Hou, Qing Yi, 2017
Multiple Myeloma Pathogenesis Targeted Therapy Bone Marrow Microenvironment Feedback Remodeling Cancer Immunology Osteolytic Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.